GPT and metabolic dysfunction-associated steatohepatitis: We could not evaluate the severity and progressive forms of NAFLD, such as nonalcoholic steatohepatitis and cirrhosis, owing to the unavailability of common surrogate serum marker-based fibrosis scoring systems, including the NAFLD fibrosis score, Fibrosis-4 Index, and ALT/AST ratio.